Esperion Therapeutics Inc (ESPR) recent quarterly performance of 13.20% is not showing the real picture
Esperion Therapeutics Inc (NASDAQ: ESPR) open the trading on Wednesday, with a bit cautious approach as it glided -8.23% to $2.23, before settling in for